Development and validation of a novel epigenetic-related prognostic signature and candidate drugs for patients with lung adenocarcinoma

Background: Epigenetic dysregulation has been increasingly proposed as a hallmark of cancer. Here, the aim of this study is to establish an epigenetic-related signature for predicting the prognosis of lung adenocarcinoma (LUAD) patients. Results: Five epigenetic-related genes (ERGs) (ARRB1, PARP1, P...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhihao, Embaye, Kidane Siele, Yang, Qing, Qin, Lingzhi, Zhang, Chao, Liu, Liwei, Zhan, Xiaoqian, Zhang, Fengdi, Wang, Xi, Qin, Shenghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351720/
https://www.ncbi.nlm.nih.gov/pubmed/34285141
http://dx.doi.org/10.18632/aging.203315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351720/
https://www.ncbi.nlm.nih.gov/pubmed/34285141
http://dx.doi.org/10.18632/aging.203315

Ejemplares similares